Food and Drug Administration officials have told some scientists and inspections staff that their layoffs will be reversed, after the job cuts led to disruptions in drug and food safety work.

Keros Therapeutics, a biotech currently engaged in a public fight with one of its largest shareholders over the future ...

Companies that interact with FDA are likely to find that the layoff of 3,500 employees on April 1, 2025, affects their dealings in a variety of ways. The cuts will likely have the greatest impact ...

Prothena has buried birtamimab for the second time. A phase 3 trial of the anti-amyloid antibody in the rare disease AL ...

Eikon Therapeutics, a Bay Area biotech startup with $1.1 billion in funding, is laying off dozens of employees and pointing ...

Layoffs at HHS create opportunities for local biotech and life sciences companies to add talent and prevent what many fear ...